Johnson amp;; Johnson to Host Pharmaceuticals Business Review

Show Health and Fitness Publications

Thu, April 25, 2013

[ Thu, Apr 25th 2013 ]: Market Wire

USANA True Health Foundation Aids Victims of China Earthquake

[ Thu, Apr 25th 2013 ]: Market Wire

ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment

[ Thu, Apr 25th 2013 ]: Market Wire

Ampio Pharmaceuticals Completes Enrollment in Run .. ING study of Ampion in Osteoarthritis of the Knee

[ Thu, Apr 25th 2013 ]: Market Wire

Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and Conference Call

[ Thu, Apr 25th 2013 ]: Market Wire

VentriPoint Receives Request for Clarification to .. k) Submission for Pulmonary Arterial Hypertension

[ Thu, Apr 25th 2013 ]: Market Wire

Threshold Pharmaceuticals Announces Presentation .. at the 12th Annual Needham Healthcare Conference

[ Thu, Apr 25th 2013 ]: Market Wire

Lexicon To Present At The Needham Healthcare Conference

[ Thu, Apr 25th 2013 ]: Market Wire

3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

Wed, April 24, 2013

[ Wed, Apr 24th 2013 ]: Market Wire

Biologix Hair Inc. Appoints Dr. Arthur G. Handal to Medical Advisory Board

[ Wed, Apr 24th 2013 ]: Market Wire

Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference

[ Wed, Apr 24th 2013 ]: Market Wire

3SBio Inc. Enters Into Amendment to Merger Agreem .. ot;;Going Privatequot;; Transaction

[ Wed, Apr 24th 2013 ]: Market Wire

Lilly Again Named One of DiversityInc's Top 50 Companies for Diversity

[ Wed, Apr 24th 2013 ]: Market Wire

Gentiva Health Services Schedules First Quarter 2 .. rnings Call And Webcast For Thursday, May 9, 2013

[ Wed, Apr 24th 2013 ]: Market Wire

Paladin Labs Announces the Canadian Launch of AmnioSense(TM)

[ Wed, Apr 24th 2013 ]: Market Wire

NuVasive(R) Announces New Office Opening in Japan

[ Wed, Apr 24th 2013 ]: Market Wire

Trimel Pharmaceuticals Corporation Completes $40 Million Equity Financing

[ Wed, Apr 24th 2013 ]: Market Wire

Top-line Data Show AcelRx Pharmaceuticals' ARX-04 .. y Endpoint in Dose-Finding Phase 2 Clinical Trial

[ Wed, Apr 24th 2013 ]: Market Wire

STATS ChipPAC Appoints James A. Norling as Chairman

[ Wed, Apr 24th 2013 ]: Market Wire

Bullish $10 Million Bet Placed by CRO After CEL-SCI Acts to Accelerate Phase III Enrollment

[ Wed, Apr 24th 2013 ]: Market Wire

Omeros to Present at the 12th Annual Needham Healthcare Conference

Tue, April 23, 2013

[ Tue, Apr 23rd 2013 ]: Market Wire

Celsion Corporation Provides Business Update

[ Tue, Apr 23rd 2013 ]: Market Wire

ISS and Glass Lewis Recommend Vote for All Digirad Nominees on the WHITE Proxy Card

[ Tue, Apr 23rd 2013 ]: Market Wire

Bioheart Discusses Current Clinical Program on Live Public Webinar

[ Tue, Apr 23rd 2013 ]: Market Wire

ISIS Pharmaceuticals Initiates a Clinical Study o .. IS-SMN Rx in Infants With Spinal Muscular Atrophy

[ Tue, Apr 23rd 2013 ]: Market Wire

Summit NW Selects Implant Sciences' QS-B220 Trace Detection System for Air Cargo Screening

[ Tue, Apr 23rd 2013 ]: Market Wire

Poorest U.S. States Rank Among Most Wasteful in Unnecessary Medication-Related Costs

[ Tue, Apr 23rd 2013 ]: Market Wire

New Data from AbbVie's Phase IIb Aviator Trial De .. l Response Rates Across Multiple Patient Types wi

[ Tue, Apr 23rd 2013 ]: Market Wire

Alchemia Announces Multi-Target Drug Discovery Co .. ation With AstraZeneca on VAST Discovery Platform

[ Tue, Apr 23rd 2013 ]: Market Wire

Ion Protona" de Life Technologies impulsa Stratified Medicine Scotland Innovation Centre

[ Tue, Apr 23rd 2013 ]: Market Wire

Ion Protona" da Life Technologies vai sustentar o Stratified Medicine Scotland Innovation Centre

[ Tue, Apr 23rd 2013 ]: Market Wire

Life Technologies' Ion Protona" to Power Stratified Medicine Scotland Innovation Centre

Mon, April 22, 2013

[ Mon, Apr 22nd 2013 ]: Market Wire

Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors

[ Mon, Apr 22nd 2013 ]: Market Wire

Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund

[ Mon, Apr 22nd 2013 ]: Market Wire

DARA and HELSINN Announce U.S. Launch of Gelclair .. ared Oral Gel for the Treatment of Oral Mucositis

[ Mon, Apr 22nd 2013 ]: Market Wire

Cheaper Gas, Airfare, Profits on Way as Commoditi .. s? - Top Small Cap Stock Focus Ahead of the Bell:

[ Mon, Apr 22nd 2013 ]: Market Wire

USANA Health Sciences Now Offering Prenatal Product

[ Mon, Apr 22nd 2013 ]: Market Wire

VentriPoint Announces Closing of Offering

[ Mon, Apr 22nd 2013 ]: Market Wire

Boston Therapeutics Addressing Unmet Medical Needs by Harnessing Complex Carbohydrate Chemistry

[ Mon, Apr 22nd 2013 ]: Market Wire

Implant Sciences' Quantum Sniffer Explosives and .. to Be Exhibited at 11th Annual Expo Seguridad Me

[ Mon, Apr 22nd 2013 ]: Market Wire

Novadaq to Release First Quarter 2013 Financial R .. sults On April 29, 2013-Conference Call to Follow

[ Mon, Apr 22nd 2013 ]: Market Wire

STAAR Surgical Announces First Quarter 2013 Results Release Date And Conference Call And Webcast

[ Mon, Apr 22nd 2013 ]: Market Wire

GSK and Theravance Announce Regulatory Submission for ANORO(TM) ELLIPTA(TM) (UMEC/VI) in Japan

Sun, April 21, 2013

[ Sun, Apr 21st 2013 ]: Market Wire

Galapagos discovers novel candidate drug to treat breast cancer

Fri, April 19, 2013

[ Fri, Apr 19th 2013 ]: Market Wire

Red Oak Partners Issues Open Letter to Digirad Co .. tion Shareholders About the Current Proxy Contest

[ Fri, Apr 19th 2013 ]: Market Wire

Ceregene Reports Data From Parkinson's Disease Phase 2b Study

[ Fri, Apr 19th 2013 ]: Market Wire

Novo Nordisk Unveils New U.S. Headquarters

[ Fri, Apr 19th 2013 ]: Market Wire

CML HealthCare Inc.'s Subsidiary, Hemostasis Refe .. rded Contract Extension with Isis Pharmaceuticals

[ Fri, Apr 19th 2013 ]: Market Wire

Ceapro Reports Full-Year 2012 Financial and Operating Results

Johnson amp;; Johnson to Host Pharmaceuticals Business Review

//health-fitness.news-articles.net/content/2013/ .. son-to-host-pharmaceuticals-business-review.html

Published in Health and Fitness on Tuesday, April 23rd 2013 at 7:45 GMT by Market Wire
^{🞛 This publication is a summary or evaluation of another publication}

Johnson & Johnson to Host Pharmaceuticals Business Review -- NEW BRUNSWICK, N.J., April 23, 2013 /PRNewswire/ --

NEW BRUNSWICK, N.J., April 23, 2013 /PRNewswire/ -- Johnson & Johnson (NYSE: [ JNJ ]) will host a review of its Pharmaceuticals business for the Investment Community beginning at 8:30 a.m. (Eastern Time) on Thursday, May 23, 2013 at the Hyatt Regency Hotel in New Brunswick, New Jersey and ending at approximately 3:00 p.m.

Paul Stoffels , M.D., Worldwide Chairman Pharmaceuticals, and Chief Scientific Officer and Joaquin Duato , Worldwide Chairman, Pharmaceuticals will host the meeting. The meeting will also feature presentations from the therapeutic area leaders within the Pharmaceuticals Research and Development organization.

The agenda for the day will be posted on the Investor Relations website on approximately May 16th.

Investors and other interested parties may access this meeting by visiting the Company's website at [ www.investor.jnj.com ] for a simultaneous webcast of the presentations.

A replay and podcast will be available shortly after the live webcast through [ www.investor.jnj.com ].

SOURCE Johnson & Johnson

RELATED LINKS
[ http://www.jnj.com ]